CRYPTO DEPEGGING

The second-largest stablecoin — a cryptocurrency that is pegged to a fiat currency — USCD depegged from the dollar, hitting an all-time low of around 88 cents over the weekend. While the coin has rebounded, it's still hovering just below the peg and could face additional volatility amid the ongoing collapse of Silicon Valley Bank. USCD reportedly held a significant amount of reserves at the embattled bank.

NEW MIGRAINE TREATMENT

The FDA has approved a new nasal spray for adults who suffer migraines. Pfizer said the spray, called Zavzpret, is considered a rapid rescue treatment and could relieve migraine pain within 15 minutes. The spray is also an alternative for people who have heart disease and other conditions that are preventing them from safely using other migraine treatments.

SLASHER SUCCESS

Scream VI topped the charts this weekend with $44.5 million dollars in ticket sales. It's the best debut in the franchise's history and a surprise box office success in the usually quiet month of March. The film follows the survivors of the last spate of Ghostface murders as they pursue a fresh start in New York City. Last year, the fifth Scream entry made about $30 million in ticket sales over a four-day holiday weekend

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More